Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Hepagene Therapeutics patents IAP inhibitors

Oct. 29, 2020

BioVaxys and Ohio State University collaborate to study SARS-CoV-2 vaccine candidate BVX-0320

Oct. 29, 2020

Histogen and Amerimmune collaborate to study emricasan for COVID-19

Oct. 28, 2020

Voclosporin studied for antiviral effects in kidney transplant recipients with COVID-19

Oct. 28, 2020

Spero Therapeutics' SPR-720 shows promise in phase I study

Oct. 28, 2020

FDA clears IND for phase Ib study of bempegaldesleukin for COVID-19

Oct. 28, 2020

UKRI conditionally approves grant funding to explore SDC-1801 as treatment of COVID-19

Oct. 28, 2020

First patient enrolled in the immune modulation domain of REMAP-COVID substudy

Oct. 28, 2020

Novel SARS-CoV-2 subunit vaccine in preclinical development

Oct. 27, 2020

ViralClear halts phase II study of merimepodib in hospitalized patients with COVID-19

Oct. 27, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...